Cardiovascular Systems (CSII) Tops Q3 EPS by 3c

Cardiovascular Systems (NASDAQ: CSII) reported Q3 EPS of ($0.25), $0.03 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $56.2 million versus the consensus estimate of $57.38 million.

GUIDANCE:

Cardiovascular Systems sees FY2022 revenue of $235-240 million, versus the consensus of $237.89 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance